MVP: Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV
Most applicable medical specialty: Infectious disease, immunology
The Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV MVP focuses on the clinical theme of promoting quality care for patients suffering from infectious disorders.
Quality
To fulfill quality requirements:
- You must select 4 quality measures from the list below
(exception for clinicians in a small practice – see # 3 below) - At least 1 measure must be an outcome measure
- If no outcome measures are available, you may report a high priority measure.
- If you are part of a small practice (i.e., 15 or fewer clinicians) reporting quality measures through Medicare Part B claims, you don’t need to report additional measures beyond the Medicare Part B claims measures available in this MVP. Reporting all of the Medicare Part B claims measures in this MVP will fulfill your quality reporting requirements.
- You must collect data for each measure for the 12-month performance period of the associated performance year (e.g., January 1, 2024- December 31, 2024).
TIP: For small practices (participating at the individual, group or subgroup level) reporting Medicare Part B claims measures: To meet data completeness requirements, you’ll need to start reporting the Medicare Part B claims measures in your selected MVP in January 2024, prior to the MVP registration period.
TIP: Make sure that you select measures that are appropriate to your patient population. Measures that don’t meet case minimum or data completeness criteria will earn zero points.
ID | Title | Specs |
065 | Appropriate Treatment for Upper Respiratory Infection (URI) | Details |
130 | Documentation of Current Medications in the Medical Record | Details |
134 | Preventive Care and Screening: Screening for Depression and Follow-Up Plan | Details |
205 | Sexually Transmitted Infection (STI) Testing for People with HIV | Details |
240 | Childhood Immunization Status | Details |
310 | Chlamydia Screening for Women | Details |
338 | HIV Viral Suppression | Details |
340 | HIV Medical Visit Frequency | Details |
387 | Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users | Details |
400 | One-Time Screening for Hepatitis C Virus (HCV) and Treatment Initiation | Details |
401 | Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis | Details |
475 | HIV Screening | Details |
487 | Screening for Social Drivers of Health | Details |
493 | Adult Immunization Status | Details |
Improvement Activities
You must report 1 of the following 3 options:
1. Two medium weighted improvement activities from the list below, or
2. One high weighted improvement activity from the list below, or
3. The IA_PCMH activity (participation in a certified or recognized patient-centered medical home
or a comparable specialty practice).
ID | Title |
IA_AHE_1 | Enhance Engagement of Medicaid and Other Underserved Populations |
IA_AHE_12 | Practice Improvements that Engage Community Resources to Address Drivers of Health |
IA_AHE_5 | MIPS Eligible Clinician Leadership in Clinical Trials or CBPR |
IA_BE_15 | Engagement of Patients, Family, and Caregivers in Developing a Plan of Care |
IA_BE_4 | Engagement of patients through implementation of improvements in patient portal |
IA_EPA_1 | Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient’s Medical Record |
IA_MVP | Practice-Wide Quality Improvement in MIPS Value Pathways |
IA_PM_11 | Regular review practices in place on targeted patient population needs |
IA_PM_14 | Implementation of methodologies for improvements in longitudinal care management for high risk patients |
IA_PM_22 | Improving Practice Capacity for Human Immunodeficiency Virus (HIV) Prevention Services |
IA_PM_6 | Use of Toolsets or Other Resources to Close Health and Health Care Inequities Across Communities (Use of toolset or other resources to close healthcare disparities across communities) |
IA_PSPA_23 | Completion of CDC Training on Antibiotic Stewardship |
IA_PSPA_32 | Use of CDC Guideline for Clinical Decision Support to Prescribe Opioids for Chronic Pain via Clinical Decision Support |
Cost
Important information to consider:
- You don’t have to submit any data for this performance category. We’ll use Medicare claims data to
calculate your cost measure performance.
(You don’t select cost measures during MVP registration. CMS will calculate your performance
on all the cost measures included in the MVP based on available Medicare claims data.) - You’ll only be scored on the cost measures in this MVP for which you meet or exceed the established
case minimum.
ID | Title | Specs |
TPCC_1 | Total Per Capita Cost (TPCC) | Details |
Foundational Layer – Promoting Interoperability
To fulfill Promoting Interoperability requirements:
- Submit the required Promoting Interoperability measures (the same as under traditional MIPS) listed below. Bonus points are available for reporting measures that aren’t required.
- If you’re reporting as a subgroup, you’ll submit your affiliated group’s data for the Promoting Interoperability performance category.
- Review if you qualify for automatic reweighting of the Promoting Interoperability performance category based on your clinician type, special status, or an approved Promoting Interoperability Performance Category Hardship Exception Application.
Clinician Types for Automatic Reweighting:
- Clinical social worker
Special Status for Automatic Reweighting:
- Ambulatory Surgical Center (ASC)-based
- Hospital-based
- Non-patient facing
- Small practice
Promoting Interoperability Performance Category Hardship Exception Qualifications:
- Decertified EHR technology
- Insufficient internet connectivity
- Experience extreme and uncontrollable circumstances (e.g., disaster, practice closure, severe financial distress, vendor issues)
- Lack control over availability of CEHRT (Certified Electronic Health Record Technology)
Note: Promoting Interoperability requirements are the same in MVPs as they are in traditional MIPS. Learn more about Promoting Interoperability requirements.
ID | Title |
PI_EP_1 | e-prescribing |
PI_EP_2 | Query of the Prescription Drug Monitoring Program (PDMP) |
PI_HEI_1 | Support Electronic Referral Loops By Sending Health Information |
PI_HEI_4 | Support Electronic Referral Loops By Receiving and Reconciling Health Information |
PI_HEI_5 | Health Information Exchange (HIE) Bi-Directional Exchange |
PI_HEI_6 | Enabling Exchange Under TEFCA |
PI_PEA_1 | Provide Patients Electronic Access to Their Health Information |
PI_PHCDRR_1 | Immunization Registry Reporting |
PI_PHCDRR_2 | Syndromic Surveillance Reporting |
PI_PHCDRR_3 | Electronic Case Reporting |
PI_PHCDRR_4 | Public Health Registry Reporting |
PI_PHCDRR_5 | Clinical Data Registry Reporting |
PI_PPHI_1 | Security Risk Analysis |
PI_PPHI_2 | High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides |
PI_INFBLO_1 | Actions to Limit or Restrict the Compatibility of CEHRT |
PI_LVITC_2 | Support Electronic Referral Loops By Receiving and Reconciling Health Information Exclusion |
PI_LVOTC_1 | Support Electronic Referral Loops By Sending Health Information Exclusion |
PI_LVPP_1 | e-Prescribing Exclusion |
PI_ONCACB_1 | ONC-ACB Surveillance Attestation |
PI_ONCDIR_1 | ONC Direct Review Attestation |
Foundational Layer – Population Health
You must select 1 population health measure at the time of MVP registration.
- You don’t have to submit any data for this measure, CMS will calculate the population health measures for you using administrative claims data.
- This measure will be excluded from scoring if the measure doesn’t have a benchmark or meet the case minimum.
- Population health isn’t a new performance category. The population health measure you select during MVP registration will be scored as part of the quality performance category provided you meet the case minimum.
- Subgroups will be evaluated at the affiliated group level.